investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
+
-
Project leads
Collaborators
Unraveling resistance to PI3K-alpha inhibitors in breast cancer
Jose Baselga
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Jianmin Zhang
Hippo signaling pathway in breast cancer disparities: a translational approach
Breast
Yibin Kang
The Role of miRNAs in Epithelial-Mesenchymal Transition and Metastasis
Breast
Angela Parrish
Axin-induced Wnt signaling in mouse embryogenesis and Wnt-related cancers
Breast
Kuo-Hsiung Lee
Novel Antitumor Agents
Breast
Matthew P Goetz
Mayo Clinic Breast Cancer SPORE
Breast
Pathology
Jing Yang
Regulation of Tumor Invasion and Metastasis by Matrix Stiffness
Breast
Zhihong Gong
Aberrant DNA methylation patterns of miRNAs and breast cancer racial disparities
Breast
Susan L Mooberry
Taccalonolides: Mechanisms of Action and Cellular Resistance
Breast
Brian D Dynlacht
Targeted Screen for Novel Chemical Modulators of Wnt/Beta-Cat Signaling Pathway.
Breast
Sign Up For Updates
Stay up to date with what's going on with
The GO Map
.